Navigation Links
Biologically Women Are More Vulnerable To HIV Infection

UN experts reported that women in India are gradually becoming more susceptible to the HIV infection and they comprise about 40 percent of India’s infected population//.

"Women are biologically more susceptible to HIV infection. Besides, gender disparities, lack of education and trafficking of women are making the situation worse," said Archana Tamang, chief of the women's human rights and human security unit, United Nations Development Fund for Women.

India has over five million AIDS/HIV infected people, including over two million women.

Tamang said: "We need to be focussed to create awareness among women between the age group of 15 and 29."

She said the role of the government, peer education and others needs to be redefined. Family members also need to provide full support.

"These people never lack in skill and efficiency but what they need is emotional support." Giving a global perspective on women infected with HIV, Tamang said out of 21 million deaths due to AIDS, nine million were accounted for by women and over four million by children.

Denis Broun, country coordinator, UNAIDS (Joint United Nations Program on HIV/AIDS), said: "Since a lot of stigma is attached to the disease, women do not come forward to take medical help."

Out of the five million HIV/AIDS population, only an estimated 65,000 people are taking medical help. While 25,000 are getting treatment in public hospitals and 10,000 are under the guidance of NGOs. Around 30,000 are getting treatment in private healthcare facilities.

"Women's vulnerability is due to two main reasons - one, the lack of adequate awareness among the community and second, their husbands. Last year around 80 percent of the women infected were through their husbands," Broun told IANS.

"The need of the hour is to reach out to young women living in extremely difficult and marginal circumstances."

However, he
'"/>




Page: 1 2

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
(Date:7/25/2008)... DALLAS, July 25 /PRNewswire/ -- BeaconEquity.c...tocks making news today., Investors can view all ...http://BeaconEquity.com/m , Today,s Trade Alerts ...),MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK...daq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and...
(Date:7/25/2008)... Expanded Relationship Based on Significant Improv...wswire/ -- MDdatacor, Inc., a leader in health,car...d providers, today,announced it has entered into a...ue to support Wellmark,s Collaboration on Quality(... collaboration between Wellmark and,primary care c...
(Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- Auto... registration statement on Form S-1 with the,Secur...osed initial public,offering of shares of its comm...be offered, all of which are expected to be offere...he offering, have not yet been,determined., J.P. ...
(Date:7/25/2008)... Whether you are an Olymp...d Warrior, there are Five Things You Need to Know ...the D.I.S.C. Spine and Sports Center , ...25, 2008 -- America,s premier athletes are heading...onditioning and sacrifice in the hopes of capturin...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...nge name for something even more surprising - a cu...ent, and its Vietnamese advocates say it ends depe...ays. This happens without side effects and without... with the Methadone treatment). If it is really a ...
...eveals for the first time one of the mechanisms by... skin cancer, grows and spreads. This discovery ma...ll arsenal of treatments available for this danger...ew melanoma treatment target in decades. Study pro...
... initiated by World HealthOrganization's (WHO) aut...le official and unofficialsources, soon after any ...o international publichealth. In a crucial decisio... WHO would carry out a through on-the-spotinvestig...
...t of elderly people over age 85 have Alzheimer’s d...mone therapy may cause some postmenopausal women t...with many cognitive disorders, including Alzheimer...ty studied more than 4,500 postmenopausal women wh...
Other Medicine News:Health News:Hope for First New Melanoma Treatment in Decades 2
(Date:7/24/2008)...e-Clinical Data Shows Increased Muscle and Blood V...als, Hearts, SUNRISE, Fla., July 24 /PRNewswire-F...ing the injection of myoblasts modified to express...nto the scar tissue of the,myocardium of rats, whi...presented at two scientific meetings -- the Intern...
(Date:7/24/2008)... New JIT Enrollment Program Speeds Oncology Pat...rmatech, Inc., a Research Management,Organization ...ical,companies to provide research and site manage...Just-in-Time (JIT) enrollment strategy. The new,tr...llicular Non-Hodgkin,s,Lymphoma, Metastatic Breast...
(Date:7/23/2008)... Nexavar is First Approved Systemic Therapy to Tre...if., July 23 /-,Bayer Healt...c. (Nasdaq:,ONXX) today announced that The New Eng...ase 3 trial demonstrating that Nexavar(R) (sorafen...y 31 percent in patients with,unresectable hepatoc...
(Date:7/23/2008)...OSTON, July 23 /- FluoroPharma Inc., ...g agents for the Positron Emission Tomography,(PET...FPET, its novel,Fluorine-18 labeled tracer for myo... second cardiovascular product to complete Phase I...ent, designed to assess the blood flow in the,hear...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 1Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 1Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 3Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 1Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 2BRCA Mutations Dont Spot All High Risk Women 18375 1BRCA Mutations Dont Spot All High Risk Women 18375 2BRCA Mutations Dont Spot All High Risk Women 18375 3
...tudy Results Presented at Society of Nuclear,Medic...RNewswire-FirstCall/ --,Immunomedics, Inc. , a bio...lonal antibodies to treat cancer and other serious...bryonic antigen,(CEA) antibody, labetuzumab, label... be safe and active when given in two doses,to pat...
...IRE)--Jun 4, 2007 - Pfizer announced today that,ax...tive inhibitor,of VEGFR 1, 2,3 (vascular endotheli...gemcitabine showed a trend towards prolonged,overa...tic cancer,compared with gemcitabine alone, accor...I trial., These data were presented at the 43rd Am...
Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 2New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 3New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: